Top

Journal of Cardiovascular Translational Research

Published in:

01-02-2011

Cardiovascular Implications in the Treatment of Obstructive Sleep Apnea

Authors: Olivier M. Vanderveken, An Boudewyns, Quan Ni, Bhavani Kashyap, Johan Verbraecken, Wilfried De Backer, Paul Van de Heyning

Published in: Journal of Cardiovascular Translational Research | Issue 1/2011

Abstract

Epidemiological studies provide strong evidence that obstructive sleep apnea (OSA) is associated with cardiovascular complications such as systemic hypertension, congestive heart failure, and atrial fibrillation. Successful OSA treatment with continuous positive airway pressure (CPAP) has resulted in coincident reductions in systemic hypertension, improvements in left ventricular systolic function, and reductions in sympathetic nervous activity. These data suggest that successful treatment of OSA may reduce cardiovascular morbidity in such patients. Although CPAP is the more successful treatment for OSA when used properly and consistently, its clinical success is often limited by poor patient and partner acceptance, which leads to suboptimal compliance. Oral appliances or upper airway surgeries are considered a second line of treatment for patients with mild to moderate OSA who do not comply with or refuse long-term CPAP treatment. Oral devices such as mandibular repositioning appliances were recently shown to improve arterial hypertension in OSA patients. Electrical stimulation of the hypoglossal nerve is a new investigational therapy for patients with moderate to severe OSA. This new treatment option, if proven effective, may provide cardiovascular benefits secondary to treating OSA.

American Academy of Sleep Medicine Task Force (1999). Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep, 22, 667–689.

Young, T., Palta, M., Dempsey, J., et al. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. The New England Journal of Medicine, 328, 1230–1235.CrossRefPubMed

Bradley, T. D., & Floras, J. S. (2003). Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation, 107, 1671–1678.CrossRefPubMed

Bradley, T. D., & Floras, J. S. (2009). Obstructive sleep apnoea and its cardiovascular consequences. Lancet, 373, 82–93.CrossRefPubMed

Somers, V. K., White, D. P., Amin, R., et al. (2008). Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council On Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation, 118, 1080–1111.CrossRefPubMed

Stoohs, R., & Guilleminault, C. (1992). Cardiovascular changes associated with obstructive sleep apnea syndrome. Journal of Applied Physiology, 72, 583–589.PubMed

Dyugovskaya, L., Lavie, P., & Lavie, L. (2002). Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. American Journal of Respiratory and Critical Care Medicine, 165, 934–939.PubMed

Ryan, S., Taylor, C. T., & McNicholas, W. T. (2005). Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation, 112, 2660–2667.CrossRefPubMed

Brooks, D., Horner, R. L., Kozar, L. F., et al. (1997). Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. Journal of Clinical Investigation, 99, 106–109.CrossRefPubMed

10.

Narkiewicz, K., Montano, N., Cogliati, C., et al. (1998). Altered cardiovascular variability in obstructive sleep apnea. Circulation, 98, 1071–1077.PubMed

11.

Chan, A. S., & Cistulli, P. A. (2009). Oral appliance treatment of obstructive sleep apnea: an update. Current Opinion in Pulmonary Medicine, 15, 591–596.CrossRef

12.

Randerath, W. J., Heise, M., Hinz, R., et al. (2002). An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest, 122, 569–575.CrossRefPubMed

13.

Marin, J. M., Carrizo, S. J., Vicente, E., et al. (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 365, 1046–1053.PubMed

14.

Selim, B., Won, C., & Yaggi, H. K. (2010). Cardiovascular consequences of sleep apnea. Clinics in Chest Medicine, 31, 203–220.CrossRefPubMed

15.

Chobanian, A. V., Bakris, G. L., Black, H. R., et al. (2003). Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension, 42, 1206–1252.CrossRefPubMed

16.

Bixler, E. O., Vgontzas, A. N., Lin, H. M., et al. (2000). Association of hypertension and sleep-disordered breathing. Archives of Internal Medicine, 160, 2289–2295.CrossRefPubMed

17.

Peppard, P. E., Young, T., Palta, M., et al. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. The New England Journal of Medicine, 342, 1378–1384.CrossRefPubMed

18.

Nieto, F. J., Young, T. B., Lind, B. K., et al. (2000). Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. Jama, 283, 1829–1836.CrossRefPubMed

19.

O’Connor, G. T., Caffo, B., Newman, A. B., et al. (2009). Prospective study of sleep-disordered breathing and hypertension: the sleep heart health study. American Journal of Respiratory and Critical Care Medicine, 179, 1159–1164.CrossRefPubMed

20.

Lloyd-Jones, D. M., Larson, M. G., Leip, E. P., et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 106, 3068–3072.CrossRefPubMed

21.

Shahar, E., Whitney, C. W., Redline, S., et al. (2001). Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. American Journal of Respiratory and Critical Care Medicine, 163, 19–25.PubMed

22.

Mehra, R., Benjamin, E. J., Shahar, E., et al. (2006). Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. American Journal of Respiratory and Critical Care Medicine, 173, 910–916.CrossRefPubMed

23.

Wang, H., Parker, J. D., Newton, G. E., et al. (2007). Influence of obstructive sleep apnea on mortality in patients with heart failure. Journal of the American College of Cardiology, 49, 1625–1631.CrossRefPubMed

24.

Sin, D. D., Fitzgerald, F., Parker, J. D., et al. (1999). Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. American Journal of Respiratory and Critical Care Medicine, 160, 1101–1106.PubMed

25.

Lloyd-Jones, D. M., Wilson, P. W., Larson, M. G., et al. (2004). Framingham risk score and prediction of lifetime risk for coronary heart disease. The American Journal of Cardiology, 94, 20–24.CrossRefPubMed

26.

Somers, V. K., Dyken, M. E., Clary, M. P., et al. (1995). Sympathetic neural mechanisms in obstructive sleep apnea. Journal of Clinical Investigation, 96, 1897–1904.CrossRefPubMed

27.

Chou, C. C., & Chen, P. S. (2008). New concepts in atrial fibrillation: mechanism and remodeling. The Medical Clinics of North America, 92, 53–63.CrossRefPubMed

28.

Condos, W. R., Jr., Latham, R. D., Hoadley, S. D., et al. (1987). Hemodynamics of the mueller maneuver in man: right and left heart micromanometry and doppler echocardiography. Circulation, 76, 1020–1028.PubMed

29.

Hall, M. J., Ando, S., Floras, J. S., et al. (1998). Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. Journal of Applied Physiology, 85, 1476–1484.PubMed

30.

Drager, L. F., Bortolotto, L. A., Pedrosa, R. P., et al. (2010). Left atrial diameter is independently associated with arterial stiffness in patients with obstructive sleep apnea: potential implications for atrial fibrillation. International Journal of Cardiology, 144(2), 257–259.CrossRefPubMed

31.

Franz, M. R., & Bode, F. (2003). Mechano-electrical feedback underlying arrhythmias: the atrial fibrillation case. Progress in Biophysics and Molecular Biology, 82, 163–174.CrossRefPubMed

32.

Shamsuzzaman, A. S., Winnicki, M., Lanfranchi, P., et al. (2002). Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation, 105, 2462–2464.CrossRefPubMed

33.

Chung, M. K., Martin, D. O., Sprecher, D., et al. (2001). C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 104, 2886–2891.CrossRefPubMed

34.

Guilleminault, C., Connolly, S. J., & Winkle, R. A. (1983). Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. The American Journal of Cardiology, 52, 490–494.CrossRefPubMed

35.

Gami, A. S., Pressman, G., Caples, S. M., et al. (2004). Association of atrial fibrillation and obstructive sleep apnea. Circulation, 110, 364–367.CrossRefPubMed

36.

Gami, A. S., Hodge, D. O., Herges, R. M., et al. (2007). Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. Journal of the American College of Cardiology, 49, 565–571.CrossRefPubMed

37.

Sullivan, C., Issa, F., Berthon-Jones, M., et al. (1981). Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet, 1, 862.CrossRefPubMed

38.

Ballester, E., Badia, J. R., Hernandez, L., et al. (1999). Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine, 159, 495–501.PubMed

39.

Giles, T. L., Lasserson, T. J., Smith, B. H., et al. (2006). Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews, 3, CD001106.

40.

Gordon, P., & Sanders, M. H. (2005). Sleep. 7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome. Thorax, 60, 68–75.CrossRefPubMed

41.

Montserrat, J. M., Ferrer, M., Hernandez, L., et al. (2001). Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. American Journal of Respiratory and Critical Care Medicine, 164, 608–613.PubMed

42.

Amfilochiou, A., Tsara, V., Kolilekas, L., et al. (2009). Determinants of continuous positive airway pressure compliance in a group of Greek patients with obstructive sleep apnea. European Journal of Internal Medicine, 20, 645–650.CrossRefPubMed

43.

De Backer, W. (1998). Non-CPAP treatment of obstructive sleep apnoea. Monaldi Archives for Chest Disease, 53, 625–629.PubMed

44.

Grote, L., Hedner, J., Grunstein, R., et al. (2000). Therapy with nCPAP: incomplete elimination of sleep related breathing disorder. The European Respiratory Journal, 16, 921–927.CrossRefPubMed

45.

Lindberg, E., Berne, C., Elmasry, A., et al. (2006). CPAP treatment of a population-based sample—what are the benefits and the treatment compliance? Sleep Medicine, 7, 553.CrossRefPubMed

46.

Duran-Cantolla, J., Aizpuru, F., Martinez-Null, C., et al. (2009). Obstructive sleep apnea/hypopnea and systemic hypertension. Sleep Medicine Reviews, 13, 323–331.CrossRefPubMed

47.

McNicholas, W. T. (2007). Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 293, R1666–R1670.PubMed

48.

Bazzano, L. A., Khan, Z., Reynolds, K., et al. (2007). Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension, 50, 417–423.CrossRefPubMed

49.

Haentjens, P., Van Meerhaeghe, A., Moscariello, A., et al. (2007). The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Archives of Internal Medicine, 167, 757–764.CrossRefPubMed

50.

Mayer, J., Becker, H., Brandenburg, U., et al. (1991). Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology, 79, 84–92.CrossRefPubMed

51.

Sanner, B. M., Tepel, M., Markmann, A., et al. (2002). Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. American Journal of Hypertension, 15, 251–257.CrossRefPubMed

52.

Shivalkar, B., Van de Heyning, C., Kerremans, M., et al. (2006). Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. Journal of the American College of Cardiology, 47, 1433–1439.CrossRefPubMed

53.

Martinez-Garcia, M. A., Gomez-Aldaravi, R., Soler-Cataluna, J. J., et al. (2007). Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. The European Respiratory Journal, 29, 951–957.CrossRefPubMed

54.

Brotman, D. J., Davidson, M. B., Boumitri, M., et al. (2008). Impaired diurnal blood pressure variation and all-cause mortality. American Journal of Hypertension, 21, 92–97.CrossRefPubMed

55.

Barbe, F., Duran-Cantolla, J., Capote, F., et al. (2010). Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. American Journal of Respiratory and Critical Care Medicine, 181, 718–726.CrossRefPubMed

56.

Kaneko, Y., Floras, J. S., Usui, K., et al. (2003). Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. The New England Journal of Medicine, 348, 1233–1241.CrossRefPubMed

57.

Mansfield, D. R., & Naughton, M. T. (2004). Sleep apnea and congestive heart failure. Minerva Medica, 95, 257–280.PubMed

58.

Kanagala, R., Murali, N. S., Friedman, P. A., et al. (2003). Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation, 107, 2589–2594.PubMed

59.

Lavie, P., Lavie, L., & Herer, P. (2005). All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. The European Respiratory Journal, 25, 514–520.CrossRefPubMed

60.

Yaggi, H. K., Concato, J., Kernan, W. N., et al. (2005). Obstructive sleep apnea as a risk factor for stroke and death. The New England Journal of Medicine, 353, 2034–2041.CrossRefPubMed

61.

Young, T., Finn, L., Peppard, P. E., et al. (2008). Sleep disordered breathing and mortality: eighteen-year follow-up of the wisconsin sleep cohort. Sleep, 31, 1071–1078.PubMed

62.

Marshall, N. S., Wong, K. K., Liu, P. Y., et al. (2008). Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep, 31, 1079–1085.PubMed

63.

Chan, A. S., & Cistulli, P. A. (2009). Oral appliance treatment of obstructive sleep apnea: an update. Current Opinion in Pulmonary Medicine. (in press).

64.

McArdle, N., Devereux, G., Heidarnejad, H., et al. (1999). Long-term use of cpap therapy for sleep apnea/hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine, 159, 1108–1114.PubMed

65.

Weaver, T. E., Kribbs, N. B., Pack, A. I., et al. (1997). Night-to-night variability in cpap use over the first 3 months of treatment. Sleep, 20, 278–283.PubMed

66.

Vanderveken, O. M., Devolder, A., Marklund, M., et al. (2008). Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. American Journal of Respiratory and Critical Care Medicine, 178, 197–202.CrossRefPubMed

67.

Ferguson, K. A., Cartwright, R., Rogers, R., et al. (2006). Oral appliances for snoring and obstructive sleep apnea: a review. Sleep, 29, 244–262.PubMed

68.

Kushida, C. A., Morgenthaler, T. I., Littner, M. R., et al. (2006). Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep, 29, 240–243.PubMed

69.

Cistulli, P. A., Gotsopoulos, H., Marklund, M., et al. (2004). Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Medicine Reviews, 8, 443–457.PubMed

70.

Gotsopoulos, H., Kelly, J. J., & Cistulli, P. A. (2004). Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep, 27, 934–941.PubMed

71.

Andren, A., Sjoquist, M., & Tegelberg, A. (2009). Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance—a 3-year follow-up. Journal of Oral Rehabilitation, 36, 719–725.CrossRefPubMed

72.

Otsuka, R., Ribeiro de Almeida, F., Lowe, A. A., et al. (2006). The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea. Sleep & Breathing, 10, 29–36.CrossRef

73.

Barnes, M., McEvoy, R. D., Banks, S., et al. (2004). Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine, 170, 656–664.CrossRefPubMed

74.

Yoshida, K. (2006). Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. The International Journal of Prosthodontics, 19, 61–66.PubMed

75.

Coruzzi, P., Gualerzi, M., Bernkopf, E., et al. (2006). Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jaw-positioning appliance. Chest, 130, 1362–1368.CrossRefPubMed

76.

Kribbs, N. B., Pack, A. I., Kline, L. R., et al. (1993). Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. The American Review of Respiratory Disease, 147, 887–895.PubMed

77.

Krieger, J., & Kurtz, D. (1988). Objective measurement of compliance with nasal CPAP treatment for obstructive sleep apnoea syndrome. The European Respiratory Journal, 1, 436–438.PubMed

78.

Rauscher, H., Formanek, D., Popp, W., et al. (1993). Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest, 103, 1675–1680.CrossRefPubMed

79.

Gagnadoux, F., Fleury, B., Vielle, B., et al. (2009). Titrated mandibular advancement versus positive airway pressure for sleep apnoea. The European Respiratory Journal, 34, 914–920.CrossRefPubMed

80.

Schwartz, A. R., Thut, D. C., Russ, B., et al. (1993). Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway. The American Review of Respiratory Disease, 147, 1144–1150.PubMed

81.

Miki, H., Hida, W., Shindoh, C., et al. (1989). Effects of electrical stimulation of the genioglossus on upper airway resistance in anesthetized dogs. The American Review of Respiratory Disease, 140, 1279–1284.PubMed

82.

Schwartz, A. R., Bennett, M. L., Smith, P. L., et al. (2001). Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Archives of Otolaryngology—Head & Neck Surgery, 127, 1216–1223.

83.

Kezirian, E. J., Boudewyns, A., Eisele, D. W., et al. (2010). Electrical stimulation of the hypoglossal nerve in the treatment of obstructive sleep apnea. Sleep Medicine Reviews, 14(5), 299–305.CrossRefPubMed

Title: Cardiovascular Implications in the Treatment of Obstructive Sleep Apnea
Authors: Olivier M. Vanderveken
An Boudewyns
Quan Ni
Bhavani Kashyap
Johan Verbraecken
Wilfried De Backer
Paul Van de Heyning
Publication date: 01-02-2011
Publisher: Springer US
Published in: Journal of Cardiovascular Translational Research / Issue 1/2011
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-010-9238-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Cardiovascular Implications in the Treatment of Obstructive Sleep Apnea

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Model-Based Design of Mechanical Therapies for Myocardial Infarction

Direct Left Atrial Pressure Monitoring in Severe Heart Failure: Long-Term Sensor Performance

Design and Rationale of the Assessment of Proper Physiologic Response with Rate Adaptive Pacing Driven by Minute Ventilation or Accelerometer (APPROPRIATE) Trial

The Role of Cardiac Electrophysiology in Myocardial Regenerative Stem Cell Therapy

Electrophysiological Mechanisms of the Anti-arrhythmic Effects of Omega-3 Fatty Acids

Non-Pharmacological, Non-Ablative Approaches for the Treatment of Atrial Fibrillation: Experimental Evidence and Potential Clinical Implications

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page